Responses
EULAR 2014: Scientific Abstracts
Poster Presentations. Psoriatic arthritis
SAT0391 A Diminished Clinical Response at 28 and 52 Weeks of Adalimumab Treatment in Patients with Psoriatic Arthritis is Associated with Anti-Drug Antibodies
Compose a Response to This Article
Other responses
No responses have been published for this article.